Added value of SPECT/CT fusion in assessing suspected bone metastasis: Comparison with scintigraphy alone and nonfused scintigraphy and CT

Radiology

Volumn 238, Issue 1, 2006, Pages 264-271

  Utsunomiya, Daisuke ^a,b   Shiraishi, Shinya ^b   Imuta, Masanori ^c   Tomiguchi, Seiji ^b   Kawanaka, Koichi ^b   Morishita, Shoji ^b   Awai, Kazuo ^b   Yamashita, Yasuyuki ^b  

^a SAISEIKAI KUMAMOTO HOSPITAL   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c KUMAMOTO REGIONAL MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BENIGN TUMOR; BONE CANCER; BONE METASTASIS; BONE SCINTISCANNING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; FUSED SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; ROC CURVE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STANDARD;

ADULT; AGED; AREA UNDER CURVE; BONE NEOPLASMS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 29444437827     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2373041358     Document Type: Article

References (35)

1. Rybak LD, Rosenthal DI. Radiological imaging for the diagnosis of bone metastases. Q J Nucl Med 2001;45:53-64.
2. Savelli G, Maffioli L, Maccauro M, De Deckere E, Bombardieri E. Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions. Q J Nucl Med 2001;45:27-37.
3. Love C, Din AS, Tomas MB, Kalapparambath TP, Palestro CJ. Radionuclide bone imaging: an illustrative review. RadioGraphics 2003;23:341-358.
4. De Maeseneer M, Lenchik L, Everaert H, et al. Evaluation of lower back pain with bone scintigraphy and SPECT. RadioGraphics 1999;19:901-912.
5. Lynn MD, Braunstein EM, Wahl RL, Shapiro B, Gross MD, Rabbani R. Bone metastases in pheochromocytoma: comparative studies of efficacy of imaging. Radiology 1986;160:701-706.
6. Gayed I, Vu T, Johnson M, Macapinlac H, Podoloff D. Comparison of bone and 2-deoxy-2-[18F|fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer. Mol Imaging Biol 2003;5:26-31.
7. Yoshioka T, Yamaguchi K, Kubota K, et al. Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer. J Nucl Med 2003;44:690-699.
8. Duarte PS, Zhuang H, Castellucci P, Alavi A. The receiver operating characteristic curve for the standard uptake value in a group of patients with bone marrow metastasis. Mol Imaging Biol 2002;4:157-160.
9. Delpassand ES, García JR, Bhadkamkar V, Podoloff DA. Value of SPECT imaging of the thoracolumbar spine in cancer patients. Clin Nucl Med 1995;20:1047-1051.
10. Bocher M, Balan A, Krausz Y, et al. Gamma camera-mounted anatomical x-ray tomography: technology, system characteristics and first images. Eur J Nucl Med 2000;27:619-627.
11. Cook GJ, Ott RJ. Dual-modality imaging. Eur Radiol 2001;11:1857-1858.
12. Kaplan IL, Swayne LC. Composite SPECT-CT images: technique and potential applications in chest and abdominal imaging. AJR Am J Roentgenol 1989;152:865-866.
13. Hasegawa BH, Wong KH, Iwata K, et al. Dual-modality imaging of cancer with SPECT/CT. Technol Cancer Res Treat 2002;1:449-458.
14. Kramer EL, Noz ME, Sanger JJ, Megibow AJ, Maguire GQ. CT-SPECT fusion to correlate radiolabeled monoclonal antibody uptake with abdominal CT findings. Radiology 1989;172:861-865.
15. Zangheri B, Messa C, Picchio M, Gianolli L, Landoni C, Fazio F. PET/CT and breast cancer. Eur J Nucl Med Mol Imaging 2004;31(suppl 1):S13S-S142.
16. Israel O, Mor M, Gaitini D, et al. Combined functional and structural evaluation of cancer patients with a hybrid camera-based PET/CT system using (18)F-FDG. J Nucl Med 2002;43:1129-1136.
17. Townsend DW, Cherry SR. Combining anatomy and function: the path to true image fusion. Eur Radiol 2001;11:1968-1974.
18. von Schulthess GK. Positron emission tomography versus positron emission tomography/computed tomography: from "unclear" to "new- clear" medicine. Mol Imaging Biol 2004;6:183-187.
19. Miyake H, Matsumoto A, Hori Y, et al. Warthin's tumor of parotid gland on Tc-99m pertechnetate scintigraphy with lemon juice stimulation: Tc-99m uptake, size, and pathologic correlation. Eur Radiol 2001;11:2472-2478.
20. Horiuchi M, Yasuda S, Shohtsu A, Ide M. Four cases of Warthin's tumor of the parotid gland detected with FDG PET. Ann Nucl Med 1998;12:47-50.
21. Shimizu A, Oriuchi N, Tsushima Y, Higuchi T, Aoki J, Endo K. High [18F] 2-fluoro-2-deoxy-D-glucose (FDG) uptake of adrenocortical adenoma showing subclinical Cushing's syndrome. Ann Nucl Med 2003;17:403-406.
22. Tamaki N, Morita K. Myocardial imaging using PET and SPECT [in Japanese]. Nippon Rinsho 1998;56:2550-2555.
23. Bombardieri E, Seregni E, Villano C, Chiti A, Bajetta E. Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumors. Q J Nucl Med Mol Imaging 2004;48:150-163.
24. Kashiwagi T, Yutani K, Fukuchi M, et al. Correction of nonuniform attenuation and image fusion in SPECT imaging by means of separate x-ray CT. Ann Nucl Med 2002;16:255-261.
25. Svanholm H, Starklint H, Gundersen HJ, Fabricius J, Barlebo H, Olsen S. Reproducibility of histomorphologic diagnoses with special reference to the kappa statistic. APMIS 1989;97:689-698.
26. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-845.
27. Efron B, Halloran E, Holmes S. Bootstrap confidence levels for phylogenetic trees. Proc Natl Acad Sci U S A 1996;93:13429-13434.
28. Rutter CM. Bootstrap estimation of diagnostic accuracy with patient-clustered data. Acad Radiol 2000;7:413-419.
29. Even-Sapir E, Keidar Z, Sachs J, et al. The new technology of combined transmission and emission tomography in evaluation of endocrine neoplasms. J Nucl Med 2001;42:998-1004.
30. Gates GF. SPECT bone scanning of the spine. Semin Nucl Med 1998;28:78-94.
31. Even-Sapir E, Martin RH, Barnes DC, Pringle CR, Iles SE, Mitchell MJ. Role of SPECT in differentiating malignant from benign lesions in the lower thoracic and lumbar vertebrae. Radiology 1993;187:193-198.
32. Reinartz P, Wieres FJ, Schneider W, Schur A, Buell U. Side-by-side reading of PET and CT scans in oncology: which patients might profit from integrated PET/CT? Eur J Nucl Med Mol Imaging 2004;31:1456-1461.
33. Delbeke D, Martin WH, Patton JA, Sandler MP. Value of iterative reconstruction, attenuation correction, and image fusion in the interpretation of FDG PET images with an integrated dual-head coincidence camera and x-ray-based attenuation maps. Radiology 2001;218:163-171.
34. Dey D, Slomka PJ, Hahn LJ, Kloiber R. Automatic three-dimensional multimodality registration using radionuclide transmission CT attenuation maps: a phantom study. J Nucl Med 1999;40:448-455.
35. LaCroix KJ, Tsui BM, Hasegawa BH, Brown JK. Investigation of the use of x-ray CT images for attenuation compensation in SPECT. IEEE Trans Nucl Sci 1994;41:2793-2799.